Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
42 participants
INTERVENTIONAL
2017-12-20
2020-07-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Achieving Control of Asthma in Children In Africa
NCT03990402
Buteyko Method for Children With Asthma
NCT02720380
Comparison of School-Based Supervised Versus Parental Supervised Asthma Therapy
NCT00110383
AQI and Childhood Asthma: an Intervention
NCT04454125
Control and Treatment of Outpatient Children with Asthma
NCT06837584
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ai Chi
Children in the intervention group will perform 12 sessions (twice a week, 40 minutes each session) of treatment with the Ai Chi Method and educational interventions in relation to asthma.
Ai Chi
Children in the intervention group will perform 12 sessions (twice a week 40 minutes each session) of treatment with the Ai Chi Method, and educational intervention in relation to asthma.
Asthma education
Children assigned to the control group will receive, along with their parents, educational interventions in relation to asthma.
Asthma education
Children assigned to the control group will receive, along with their parents, educational interventions in relation to asthma.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ai Chi
Children in the intervention group will perform 12 sessions (twice a week 40 minutes each session) of treatment with the Ai Chi Method, and educational intervention in relation to asthma.
Asthma education
Children assigned to the control group will receive, along with their parents, educational interventions in relation to asthma.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Regular inhaled corticosteroids with no change in dose in the preceding 4 weeks;
* Children cannot present: other respiratory disease (such as cystic fibrosis, bronchiectasis, tuberculosis), obesity, retinal detachment, hypertensive crisis, congenital heart defect, pulmonary edema, history of lobectomy or lung segmentectomy, respiratory infections 15 days prior to the evaluations.
Exclusion Criteria
* Give up participating in the research and present acute symptoms of respiratory tract during the assessments.
7 Years
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidade Federal do Rio Grande do Norte
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Karla Morganna Pereira Pinto de Mendonça
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Karla Mendonça, PT, PhD
Role: PRINCIPAL_INVESTIGATOR
Universidade Federal do Rio Grande do Norte
Renata Tomaz, PT, PhD's Student
Role: PRINCIPAL_INVESTIGATOR
Universidade Federal do Rio Grande do Norte
Ada Jácome, PT, PhD's student
Role: PRINCIPAL_INVESTIGATOR
Universidade Federal do Rio Grande do Norte
Thayla Amorim, PT, Ms
Role: PRINCIPAL_INVESTIGATOR
Universidade Federal do Rio Grande do Norte
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universidade Federal do Rio Grande do Norte (UFRN)
Natal, Rio Grande do Norte, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
67253617.4.0000.5537
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.